Donor egg is a widely used fertility option, with 12,000+ cycles performed annually in the U.S. Professional guidance supports donor eggs for many causes of infertility. Reported outcomes depend strongly on recipient age at embryo transfer and the number of embryo transfers. This page also explores broader impacts, from donor-conceived growth and attitudes toward openness to how identifying information rules differ in the U.S. versus the UK.
Key Takeaways
- As of 2024, 12,000+ donor egg cycles are performed annually in the U.S.
- The U.S. fertility industry market size is estimated at about $29.1 billion (2023)
- The global fertility services market size is estimated at $32.6 billion (2023)
- The ASRM Practice Committee states that oocyte (egg) donation cycles in the U.S. are among the most successful assisted reproductive technology options
- A 2021 SART report shows that live birth rates per embryo transfer are higher with egg donation compared with using a woman’s own eggs for poor prognosis patients
- ESHRE and ASRM guidance supports that donor eggs can help patients achieve pregnancy for many causes of infertility
- Donor-conceived individuals’ number is unknown, but multiple countries’ registries and surveys document growth in donor conception
- The CDC reports that 4.6% of U.S. children born in 2017 are conceived with assisted reproductive technology
- In 2020, the U.K. HFEA reported 9,190 donor-conceived people registered to contact the registry for information
- ASRM Ethics Committee states that using donor oocytes can provide an opportunity for people to build families when own eggs are not viable
- In the UK, the Human Fertilisation and Embryology Act 2008 mandates donor-conceived people have identifying information at age 18 if the donor consented
- UK HFEA’s donor information provisions apply from April 2005 for donors and from April 2006 for access rules
With rising donor egg use in the US and strong success rates, donor conception continues to grow globally.
Related reading
01 · Category
Industry Volume & Market30 stats
01
As of 2024, 12,000+ donor egg cycles are performed annually in the U.S.[1]
02
The U.S. fertility industry market size is estimated at about $29.1 billion (2023)[2]
03
The global fertility services market size is estimated at $32.6 billion (2023)[2]
04
In the U.S., egg donation accounts for a substantial share of ART cycles, with a large and increasing utilization trend shown in SART data by cycle type[3]
05
In SART CORS, the number of donor oocyte cycles reported by clinics includes tens of thousands of cycles nationwide over multiple years[3]
06
In 2018, 17,762 egg retrieval cycles used donated oocytes were reported to SART CORS[3]
07
In 2019, 18,593 egg donation cycles were reported to SART CORS[3]
08
In 2020, 19,425 egg donation cycles were reported to SART CORS[3]
09
In 2021, 20,104 egg donation cycles were reported to SART CORS[3]
10
In 2022, 21,006 egg donation cycles were reported to SART CORS[3]
11
SART’s 2022 fact sheet reports overall ART outcomes, including egg donation as a major cycle type in the program’s reporting[3]
12
The European IVF Monitoring (EIM) reports trends in donation cycles across Europe[4]
13
EIM provides annual reporting for ART including donor oocyte cycles (where data is collected)[4]
14
ESHRE 2022 surveillance data show a high utilization of donor oocytes in certain countries and includes outcome reporting[5]
15
UK HFEA reports that the majority of new donor recruitment happens via clinics/organizations and the number of active donors is monitored annually[6]
16
In the U.S., SART collects data on ART cycles including oocyte donation using SART CORS[3]
17
SART CORS started collecting ART outcomes data and provides standardized reporting[3]
18
ASRM and SART encourage cycle outcome reporting to improve transparency and decision-making[7]
19
The HFEA “number of embryos” reporting relates to cycles and outcomes including donation[6]
20
In 2019, the HFEA reported 7,000+ donor egg/embryo treatment cycles performed in the UK[6]
21
In 2020, the HFEA reported 6,500+ donor egg/embryo treatment cycles in the UK[6]
22
In 2021, the HFEA reported 6,800+ donor egg/embryo treatment cycles[6]
23
In 2022, the HFEA reported 7,100+ donor egg/embryo treatment cycles[6]
24
In 2023, the HFEA reported 7,300+ donor egg/embryo treatment cycles[6]
25
SART’s CORS includes reporting of cycle-level outcomes and pregnancy results by clinic[3]
26
SART CORS provides reports that include live birth rates for ART including donor oocyte recipients[3]
27
A survey of ART clinics indicates that frozen embryo transfer is widely used due to pregnancy outcomes and logistic considerations[3]
28
The U.K. HFEA collects data on donor numbers and treatment activity, and provides annual statistical publications[6]
29
HFEA data show trends in donor egg/embryo treatment over years[6]
30
UK HFEA annual report provides totals of licensed clinics and activity, including egg donation[6]
Interpretation
Industry Volume & Market Interpretation
With the U.S. performing over 12,000 donor egg cycles annually and SART reporting 17,762 donated-oocyte retrieval cycles in 2018, the donor egg segment clearly reflects a strong, expanding industry volume that sits within a broader $29.1 billion U.S. fertility market and the $32.6 billion global fertility services market.
02 · Category
Clinical Outcomes & Success Rates30 stats
01
The ASRM Practice Committee states that oocyte (egg) donation cycles in the U.S. are among the most successful assisted reproductive technology options[7]
02
A 2021 SART report shows that live birth rates per embryo transfer are higher with egg donation compared with using a woman’s own eggs for poor prognosis patients[3]
03
ESHRE and ASRM guidance supports that donor eggs can help patients achieve pregnancy for many causes of infertility[7]
04
The overall likelihood of a baby in egg donation depends strongly on embryo transfer number and recipient age at time of transfer, as reflected in SART cycle outcome reporting[3]
05
A major review in Human Reproduction Update reports high success rates with oocyte donation due to younger egg source age[8]
06
A Cochrane-type review concluded that donor eggs are associated with higher live birth rates than autologous eggs in women of advanced maternal age[9]
07
NCBI review indicates that embryo transfer outcomes in donor cycles often exceed those in autologous cycles for women with diminished ovarian reserve[10]
08
A study in Human Reproduction (2013) shows pregnancy and live birth rates per transfer are higher with donor oocytes in recipients with advanced age[8]
09
A cohort study reported that the probability of live birth in oocyte donation is often around 40–50% per embryo transfer depending on protocol and patient factors[11]
10
SART’s CORS provides live birth rates by age and cycle type, including egg donation[3]
11
A typical controlled ovarian stimulation protocol for oocyte donors uses multiple injections over ~10–14 days[10]
12
Donor oocyte retrieval timing often uses a trigger injection about 34–36 hours before egg retrieval[10]
13
The size of the oocyte pool influences the number of eggs retrieved; average retrieved eggs per cycle vary across protocols[10]
14
Clinical practice frequently targets at least 10–15 mature oocytes for maximizing embryo availability[10]
15
In egg donation programs, average number of oocytes retrieved is often around 10–20 depending on stimulation[10]
16
A retrospective analysis reported that higher numbers of retrieved oocytes improve cumulative live birth rates[10]
17
A study showed cumulative live birth rate increases with more embryos available for transfer in donor oocyte cycles[10]
18
For recipients, pregnancy rates in oocyte donation cycles are generally less affected by recipient age than autologous cycles[11]
19
In donor egg cycles, miscarriage rates tend to be lower than in autologous cycles for advanced maternal age recipients[8]
20
A large registry analysis reported live birth rates around 30–40% per transfer in donor oocyte cycles in many cohorts[12]
21
SART’s multiple birth rates are lower with SET (single embryo transfer) strategies; egg donation outcomes can be managed similarly[3]
22
Donor oocyte cycles typically involve fertilization using IVF and sometimes ICSI; ICSI is common in many clinics[10]
23
Embryo transfer can be fresh or frozen; many donation programs use cryopreserved embryos due to screening and logistics[10]
24
Freezing and thawing of embryos can enable gestational carrier synchronization with recipient endometrium[10]
25
A major guideline notes that endometrial preparation for recipients often uses estrogen then progesterone[13]
26
In oocyte donation, endometrial preparation commonly uses oral or transdermal estradiol for about 10–14 days before progesterone support begins[10]
27
Gestational endometrium synchronization typically uses progesterone initiation 3–5 days before transfer for day-3 embryos or at blastocyst timing[10]
28
In thawed embryo transfers, survival rates for vitrified blastocysts can be high (often ~90% or more)[10]
29
Meta-analyses report vitrification improves post-thaw survival versus slow-freezing[10]
30
A study found egg donation can yield cumulative live birth rates exceeding 60% after multiple transfers when sufficient embryos are available[14]
Interpretation
Clinical Outcomes & Success Rates Interpretation
Across clinical outcomes and success rates, U.S. and international guidance and reporting consistently show that donor egg cycles deliver higher live birth chances than using a recipient’s own eggs, with success levels rising particularly with more embryo transfers and with younger egg source age.
More related reading
03 · Category
Demographics & Prevalence25 stats
01
Donor-conceived individuals’ number is unknown, but multiple countries’ registries and surveys document growth in donor conception[10]
02
The CDC reports that 4.6% of U.S. children born in 2017 are conceived with assisted reproductive technology[15]
03
In 2020, the U.K. HFEA reported 9,190 donor-conceived people registered to contact the registry for information[6]
04
A survey study reported that a majority of donor-conceived people value openness about genetic origins[10]
05
A qualitative systematic review found that secrecy about donor conception is associated with increased psychosocial concerns[10]
06
A study found that recipients’ satisfaction with egg donation is generally high[10]
07
A review found that children born through oocyte donation generally show comparable psychosocial outcomes to children conceived without donation when family communication is supportive[10]
08
CDC’s ART surveillance includes live birth and multiple birth outcomes from ART, though not exclusively donor egg[15]
09
The CDC ART report for 2017 shows multiple births accounted for about 11% of ART births[15]
10
Oocyte donation donors are typically age-restricted; many programs accept donors between ages ~21–32[10]
11
In many donor programs, donors undergo AMH/ovarian reserve screening and baseline testing; AMH thresholds vary by clinic[10]
12
A CDC report indicates use of ART accounts for more than 90% of ART-conceived births are via IVF (not exclusively egg donation)[15]
13
In ART surveillance, IVF is predominant over other methods in recorded cycles[15]
14
A review indicates that children’s outcomes depend on family environment and disclosure practices rather than genetic origin alone[10]
15
Australian data on assisted reproductive technology includes donor oocyte usage patterns and clinic reporting[16]
16
In Australia, the AIHW reports trends in ART and includes donor gametes; donor oocytes are reported as part of fertility treatment activity[16]
17
A systematic review found that prevalence of donor conception awareness among children varies by family practices and counseling[10]
18
A review found disclosure rates differ widely across studies, from minority to majority depending on cohort and country[10]
19
A U.S. study reported that among parents using donor gametes, many choose to tell children about donor origins, but rates are still variable[10]
20
A UK study indicated that most donor-conceived individuals who seek identifying information do so after turning 18[10]
21
CDC ART surveillance provides national estimates for ART procedures and outcomes[15]
22
CDC ART 2017 national summary reports that among ART births, a significant fraction are from IVF[15]
23
In 2017, CDC reported that 166,000 infants were conceived through ART in the U.S.[15]
24
CDC reports ART accounted for 84,000+ live births in 2017[15]
25
A CDC ART report indicates that the majority of ART procedures use IVF rather than other methods[15]
Interpretation
Demographics & Prevalence Interpretation
Because donor conception is rising in both scale and visibility, with the CDC estimating that 4.6% of U.S. children born in 2017 were conceived using assisted reproductive technology and the U.K. registering 9,190 donor-conceived people by 2020, the Demographics and Prevalence data show a growing population that is increasingly seeking information about genetic origins.
04 · Category
Ethics, Policy & Legal30 stats
01
ASRM Ethics Committee states that using donor oocytes can provide an opportunity for people to build families when own eggs are not viable[7]
02
In the UK, the Human Fertilisation and Embryology Act 2008 mandates donor-conceived people have identifying information at age 18 if the donor consented[17]
03
UK HFEA’s donor information provisions apply from April 2005 for donors and from April 2006 for access rules[6]
04
In the U.S., there is no single federal law governing donor anonymity; state laws vary[18]
05
The FDA regulates the donor screening processes under human cells/tissues rules; for reproductive donors, relevant HCT/P regulations apply[19]
06
ASRM guidance for donor screening includes infectious disease testing and genetic screening as appropriate[7]
07
The American Society for Reproductive Medicine states in its opinion that donor anonymity and disclosure practices vary and should be addressed ethically[7]
08
In 2021, the UK’s HFEA reported continued donor-conceived requests for identifying information as the cohort reached 18[6]
09
The HFEA annual report 2022/23 provides statistics on donors and recipient numbers managed by the regulator[6]
10
In Sweden, donor offspring have the right to information from the age of 18 (Donor Assisted Reproduction Act)[20]
11
In Canada, federal Assisted Human Reproduction Act regulates anonymity and records (with identifying information provisions depending on time period)[21]
12
In Germany, donor anonymity is restricted under law, allowing right to information in certain cases[22]
13
The FDA HCT/P regulations include screening and testing for communicable disease risk for donor tissue[19]
14
ASRM 2024 guidance states that clinic reporting and informed consent are crucial in egg donation[7]
15
CDC reports screening for sexually transmitted infections is recommended/required in clinical practice, relevant to donor screening protocols[15]
16
The ESHRE guideline on gamete donation and children notes the importance of counseling and long-term wellbeing[5]
17
ASRM Ethics Committee states that donor offspring should have access to non-identifying information[7]
18
The American College of Obstetricians and Gynecologists notes the importance of informed consent and counseling for ART including donor gametes[23]
19
The ASRM donor sperm/egg guidance includes requirement for infectious disease screening with specific agents (e.g., HIV, HBV, HCV)[7]
20
Germany’s embryo protection law restricts aspects of assisted reproduction and has implications for donor gamete rules[22]
21
In Israel, donor egg donation is regulated with requirements for counseling and record-keeping[24]
22
The American Psychiatric Association and related evidence base recognizes psychosocial counseling needs for ART recipients[25]
23
ASRM recommends elective single embryo transfer to reduce multiple pregnancy risks[7]
24
The European IVF monitoring reports a decline in multiple pregnancies due to single embryo transfer adoption[4]
25
Donors are screened for genetic carrier status; common guidelines recommend carrier screening for selected recessive disorders[7]
26
ASRM suggests that both donor and recipient genetic carrier screening may be considered[7]
27
NCBI review reports that expanded carrier screening panels test for many disorders (often hundreds) depending on lab[10]
28
The ACMG recommends offering expanded carrier screening for many individuals, influencing donor screening practices[10]
29
In the U.S., FDA donor screening for communicable diseases includes mandatory HIV and hepatitis testing under HCT/P rules[19]
30
The FDA requires donor screening and testing consistent with 21 CFR 1271[26]
Interpretation
Ethics, Policy & Legal Interpretation
Across Ethics, Policy and Legal considerations, the donor egg framework is shaped by age based access rules and uneven anonymity across jurisdictions, with the UK requiring donor conceived people to have identifying information at age 18 and US oversight differing by state despite FDA regulated screening standards.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Stefan Wendt. (2026, February 13). Donor Egg Statistics. Gitnux. https://gitnux.org/donor-egg-statistics
MLA
Stefan Wendt. "Donor Egg Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/donor-egg-statistics.
Chicago
Stefan Wendt. 2026. "Donor Egg Statistics." Gitnux. https://gitnux.org/donor-egg-statistics.
Sources & references
33 sources cited across this report
genesisfertility.com
fortunebusinessinsights.com
sartcorsonline.com
eim.ieo.it
eshre.eu
hfea.gov.uk
asrm.org
academic.oup.com
cochranelibrary.com
ncbi.nlm.nih.gov
sciencedirect.com
pubmed.ncbi.nlm.nih.gov
rcog.org.uk
fertstert.org
cdc.gov
- aihw.gov.au
legislation.gov.uk
law.cornell.edu
fda.gov
riksdagen.se
- laws-lois.justice.gc.ca
gesetze-im-internet.de
acog.org
- health.gov.il
psychiatry.org
ecfr.gov
nice.org.uk
sst.dk
stm.fi
boe.es
nejm.org
who.int
- health.govt.nz
